chr11-108315883-G-C

Variant summary

Our verdict is Uncertain significance.
+1 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 1 classification points (ACMG Germline Pathogenicity v2019). PM1_SupportingPM2BP6_Moderate

The NM_000051.4(ATM):c.6067G>C (p.Gly2023Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.47). Variant has been reported in ClinVar as Benign/Likely Benign (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.G2023E: Uncertain_significance (ClinVar VariationId 453610, 2 stars); p.G2023= (synonymous): Likely_benign (ClinVar VariationId 1751358, 1 star); p.G2023R: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 127416); p.G2023V: Uncertain_significance (ClinVar VariationId 3801988, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Ataxia telangiectasia (AT).

Frequency

Genomes: not found (cov: 32)

Consequence

ATM
NM_000051.4 missense

Scores

6
11
2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 9.47

Publications

27 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Natera, Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, G2P, Orphanet, Natera, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and obsolete negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Jun 2026]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000051.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

PM1Mutational hot spot or critical domain
Missense neighbourhood moderate hotspot (≥2 P/LP within ±8 AA, OR ≥ 2 vs. background) — PM1 supporting; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 2 pathogenic, 4 benign (OR vs. background: 2.8).
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (threshold 0.0001) — PM2 moderate.
BP6Reputable source reports benign
ClinVar 1-star benign — moderate (BP6); ClinVar germline classification: Benign/Likely Benign, 1 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ATM NM_000051.4
MANE Select
HGVSc / HGVSpc.6067G>Cp.Gly2023Arg
Exon rankExon 41 of 63
missense
Prot: NP_000042.3
ATM NM_001351834.2
HGVSc / HGVSpc.6067G>Cp.Gly2023Arg
Exon rankExon 42 of 64
missense
Prot: NP_001338763.1UniProt: Q13315
C11orf65 NM_001330368.2
HGVSc / HGVSpc.641-6812C>G
Exon rankIntron 6 of 6
intron
Prot: NP_001317297.1

Ensembl Transcripts

ATM ENST00000675843.1
MANE Select
HGVSc / HGVSpc.6067G>Cp.Gly2023Arg
Exon rankExon 41 of 63
missense
Prot: ENSP00000501606.1UniProt: Q13315
ATM ENST00000452508.7
TSL:1
HGVSc / HGVSpc.6067G>Cp.Gly2023Arg
Exon rankExon 42 of 64
missense
Prot: ENSP00000388058.2UniProt: Q13315
ATM ENST00000527805.6
TSL:1
HGVSc / HGVSpn.*1131G>C
Exon rankExon 39 of 61
3_prime_UTR
Prot: ENSP00000435747.2UniProt: E9PIN0

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:32
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Ataxia-telangiectasia syndrome (1)

Computational Scores

AlphaGenome AVI
Pathogenic25
AlphaMissense
Uncertain0.42
BayesDel_addAF
Pathogenic0.21D
BayesDel_noAF
Uncertain0.070
CADD
Uncertain25
DANN
Pathogenic1.0
DEOGEN2
Benign0.14T
Eigen
Pathogenic0.80
Eigen_PC
Pathogenic0.78
FATHMM_MKL
Pathogenic0.99D
FuncVEP CTI
Pathogenic0.63
GPN-Star LLR
N/A-10
GPN-Star score
N/A10
LIST_S2
Uncertain0.94D
M_CAP
Uncertain0.27D
MetaRNN
Pathogenic0.86D
MetaSVM
Benign-1.1T
Mutation Taster
N/A12/88disease causing
MutationAssessor
Uncertain2.6M
PhyloP100
Pathogenic9.5
PrimateAI
Uncertain0.66T
PROVEAN
Uncertain-3.5D
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
REVEL
Uncertain0.52
Sift
Uncertain0.0030D
Sift4G
Uncertain0.0030D
Varity_R
N/A0.81
VESM-3B
Benign-8.2
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.